Skip to main content
. 2016 Sep 30;38(5):1433–1442. doi: 10.3892/ijmm.2016.2763

Figure 1.

Figure 1

Rolipram (ROL) attenuates mechanical allodynia and thermal hyperalgesia in rats with bone cancer pain (BCP). (A) The intrathecal administration of ROL at doses of 12.5, 25, 50 and 100 μg/kg significantly attenuated BCP. (B) The paw mechanical withdrawal threshold and (C) the paw withdrawal latency were assessed in different groups of rats at the dose of 50 μg/kg. (D) The effects of ROL at various doses on motor performance were examined by the rotarod test. **p<0.01 vs. BCP + vehicle group; ##p<0.01 vs. sham-operated group (sham). Eight rats were included in each group.